Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN)

Circulation. 2013 Apr 16;127(15):1630-5. doi: 10.1161/CIRCULATIONAHA.112.000779.
No abstract available

Publication types

  • Guideline
  • Research Support, N.I.H., Extramural

MeSH terms

  • Biomarkers
  • Cardiovascular Agents / adverse effects
  • Cardiovascular Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / therapy
  • Clinical Trials, Phase II as Topic / methods*
  • Clinical Trials, Phase II as Topic / standards
  • Clinical Trials, Phase II as Topic / statistics & numerical data
  • Clinical Trials, Phase III as Topic
  • Dose-Response Relationship, Drug
  • Drug-Related Side Effects and Adverse Reactions
  • Endpoint Determination
  • Heart Function Tests
  • Humans
  • Multicenter Studies as Topic
  • Quality of Life
  • Research Design
  • Sample Size
  • Stem Cell Transplantation / adverse effects

Substances

  • Biomarkers
  • Cardiovascular Agents